Digital FH25: On the future of health, with Frontiers Health Chairma... In the final episode of our special Frontiers Health limited series, conference Chairman Roberto Ascione discusses his favourite moments and insights.
Digital Sponsored Precision medicine meets machine learning: AI and oncology b... A close examination of the current and future role of AI in biomarker discovery and the challenges that developers face in leveraging it.
Digital AI is reshaping drug discovery - Now it must prove it can be... As innovation pushes the boundaries of speed and scale, a question remains: can we use transparency as a way to prove safety and build public trust?
Digital Sponsored Axtria Ignite 2025: A VIP roundtable on agentic AI At Axtria Ignite 2025, over 20 pharma senior executives stepped into a VIP roundtable to discuss how best to unlock agentic AI’s tranformative value.
Digital Improving ROI on AI investments and data quality, with Dr Ja... Dr Jay Anders, chief medical officer for Medicomp Systems, discusses why he believes that the only way to solve AI ROI issues is to solve data quality
Digital Agentic AI, culture shifts, and commercialisation today: Ant... Hear Anthony Cilento, VP, data science & customer insights, at Bayer, in a post-Axtria Ignite 2025 discussion on the conference and agentic AI.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.